Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed EBT Margin for 3 consecutive years, with 45761.31% as the latest value for Q1 2018.

  • Quarterly EBT Margin changed N/A to 45761.31% in Q1 2018 from the year-ago period, while the trailing twelve-month figure was 158669.6% through Dec 2018, down 15714041.0% year-over-year, with the annual reading at 9866.63% for FY2025, 74134.0% up from the prior year.
  • EBT Margin for Q1 2018 was 45761.31% at ENDRA Life Sciences, down from 33498.39% in the prior quarter.
  • The five-year high for EBT Margin was 310.52% in Q2 2016, with the low at 45761.31% in Q1 2018.
  • Average EBT Margin over 3 years is 13646.3%, with a median of 1397.52% recorded in 2017.
  • Peak annual rise in EBT Margin hit -278887bps in 2017, while the deepest fall reached -3336478bps in 2017.
  • Over 3 years, EBT Margin stood at 133.61% in 2016, then crashed by -24971bps to 33498.39% in 2017, then crashed by -37bps to 45761.31% in 2018.
  • According to Business Quant data, EBT Margin over the past three periods came in at 45761.31%, 33498.39%, and 316.69% for Q1 2018, Q4 2017, and Q3 2017 respectively.